Skip to main content

Preliminary IND-enalbing Studies of OP449 as a Novel Cancer Therapeutic

Printer-friendly versionPrinter-friendly versionSend by emailSend by email
Award date: 
May 14, 2013
Award amount: 
$250,000
Organization name: 
Oncotide Pharmaceuticals
Principal Investigator: 
Christensen, Dale J.
Grant program category: 
Business Financing
Grant program name: 
Small Business Research Loan
Region: 
Research Triangle

Oncotide Pharmaceuticals, Inc. is developing a new class of anti-cancer drugs targeted at hematologic and solid cancers. The company will use its Small Business Research Loan to fund preclinical development of its lead compound. [SP - SEE EMAIL]

Fiscal year: 
2013